Officer of Protagonist Therapeutics, Inc. (NASDAQ:PTGX), a $2.2 billion market cap biotech company, recently reported the sale of 3,640 shares of common stock on January 16, 2025. The transactions ...
Susan Blount, a director at Cavco Industries Inc. (NASDAQ:CVCO), recently executed a series of stock transactions as detailed in a Form 4 filing with the Securities and Exchange Commission. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback